Lyme Carditis: When Lyme Disease Affects the Heart

Lyme carditis may occur when Lyme disease bacteria penetrates heart tissue. Learn how Phyllanthus niruri may help.

---

Lyme disease is caused by a powerful and elusive bacterium, Borrelia burgdorferi, that can spread throughout the body if not addressed promptly. Over time, it can affect multiple systems and organs, including the joints, central nervous system, and heart.

One of the more serious but less common complications is Lyme carditis, which occurs in roughly 4–10% of patients with Lyme borreliosis. This condition typically develops in the early stages of the disease. When the immune system detects B. burgdorferi in heart tissue, it triggers inflammation as a defense mechanism.

Unfortunately, this inflammation can disrupt the electrical signals that control heartbeat, blocking the connection between the upper (atria) and lower (ventricles) chambers. This “heart block” can occur in varying degrees, potentially altering the heart’s rhythm.

Symptoms of Lyme carditis can include:

• Palpitations
• Shortness of breath
• Fainting
• Chest pain

These symptoms are almost always accompanied by fever, body aches and pains, and even more specific Lyme disease symptoms, such as the infamous erythema migrans rash, aka “the bullseye” that sometimes appears after a tick bite.

Recognizing these symptoms early is essential for timely diagnosis and treatment.

Early Recognition of Lyme Carditis Can Save Lives

Lyme carditis is one of the rarest complications of Lyme borreliosis, but when it does occur, it demands immediate attention. This condition typically develops within the first 2–3 months after infection—an important window when antibiotics are most effective.

The key danger in Lyme carditis is the development of a heart block, a disruption in the electrical signals that control the heartbeat. Without intervention, a mild 1st-degree block can rapidly progress to a 3rd-degree block, where the heart fails to pump blood consistently—a potentially fatal situation.

According to LymeDisease.org, high-degree heart block is typically treated by implanting a permanent pacemaker. However, in cases caused by Lyme carditis, the heart block often resolves with antibiotic therapy. Correctly identifying Lyme carditis as the cause can prevent unnecessary pacemaker implantation and ensure that patients receive the right treatment at the right time.

Early recognition is critical—prompt diagnosis and antibiotics can mean the difference between a quick recovery and a life-threatening emergency.

Misperceptions and Misconceptions About Lyme Carditis

Here are some common misperceptions and misconceptions about Lyme carditis – and why they can be dangerous:

1. “Lyme carditis is extremely rare, so it’s not worth considering.”
   While Lyme carditis is less common than other Lyme disease symptoms, it affects 4–10% of Lyme patients and can be life-threatening if missed. Rarity doesn’t mean irrelevance—especially when early treatment can prevent severe complications.
2. “Heart symptoms mean it’s a primary heart condition, not Lyme disease.”
   Palpitations, chest pain, fainting, or shortness of breath can be mistakenly attributed to heart disease alone. Without considering Lyme—particularly in patients with recent tick exposure—doctors may miss the root cause.
3. “If you have Lyme carditis, you’ll definitely have the bullseye rash.”
   The hallmark erythema migrans rash appears in only a portion of Lyme cases. Its absence does not rule out Lyme or Lyme carditis.
4. “A pacemaker is always needed for heart block.”
   In non-Lyme heart block cases, a pacemaker may be standard, but in Lyme carditis, antibiotics often resolve the block—avoiding unnecessary surgery if diagnosed correctly.
5. “Lyme carditis develops only in late-stage Lyme disease.”
   It usually occurs early—within the first 2–3 months of infection—making timely recognition crucial for effective treatment.

Phyllanthus niruri Lyme Carditis Support

When the immune system responds to an infection in the body, its first response is inflammation, which is what happens in the case of Lyme carditis. The immune system is put on high alert and works hard to fight the infection.

In some instances, the immune system can be under constant attack from both Lyme disease bacteria and Lyme carditis, as well as daily stress from work, environment, relationships, etc. When this combination of factors occurs, the immune system can become weakened and compromised.

Phyllanthus niruri, also known as Chanca Piedra and Stone Breaker, may provide phytochemical support for a balanced immune system.

Linden Botanicals sells Phyllanthus niruri as an herbal tea and an herbal extract. It has been traditionally used to help the immune and lymphatic systems combat viruses and bacteria, support the digestive system and renal system, and reduce stress on the pancreatic system.

An adaptogenic and phytochemically rich herb found in South America, Phyllanthus niruri is an anti-bacterial, antiviral, anti-plasmodial plant used in traditional medicine to attack the spirochete that causes syphilis.

This same spirochete is bacteria that is similar to that of Lyme borreliosis, which is why it may prove helpful for those suffering from Lyme carditis.

To learn more about Phyllanthus niruri, check out the Phyllanthus FAQ.

Cryptolepis

Cryptolepis sanguinolenta, offered as a pure herbal extract by Linden Botanicals, may provide targeted support for individuals dealing with Lyme disease and potentially complications like Lyme carditis, based on its traditional uses and modern research findings.

A Frontiers in Medicine study led by Johns Hopkins researchers found that Cryptolepis was the only herbal extract tested to completely eradicate dormant “persister” forms of Borrelia burgdorferi—the bacterium responsible for Lyme disease. These persister cells are thought to contribute to ongoing symptoms and treatment resistance, making them a key concern in chronic or complicated cases.

By helping to address both actively growing and dormant bacteria, Cryptolepis may support more complete microbial clearance when used as part of a comprehensive Lyme protocol.

Cryptolepis also shows broad-spectrum antimicrobial activity, including activity against co-infections like Babesia and Bartonella, which sometimes accompany Lyme and may worsen inflammatory or cardiac complications. Its anti-inflammatory and immune-modulating properties may further help calm infection-related inflammation, which is a major factor in Lyme carditis, where swelling in the heart tissue can disrupt normal electrical signaling.

Because early, effective microbial control and inflammation management are both critical for preventing or minimizing complications, Cryptolepis extract from Linden Botanicals could be a valuable natural ally—especially for those seeking science-informed, sustainably sourced, and rigorously tested herbal support.

To learn more about Cryptolepis, check out the Cryptolepis FAQ.

Cistus incanus

Cistus incanus, available as a high-quality herbal extract from Linden Botanicals, may offer multiple layers of support for individuals managing Lyme disease and complications such as Lyme carditis.

Known for its broad-spectrum antimicrobial properties, Cistus incanus has been studied for its ability to help disrupt biofilms—protective layers formed by bacteria like Borrelia burgdorferi that make infections harder to eradicate. By breaking down these biofilms, Cistus may improve the effectiveness of the body’s immune response and other antimicrobial therapies against both active and dormant Lyme bacteria.

Cistus incanus also exhibits antiviral, antibacterial, and anti-inflammatory activity. For those with Lyme carditis, the herb’s inflammation-calming effects may help reduce swelling in cardiac tissues, potentially supporting healthier heart rhythm and function while the underlying infection is addressed. Its antioxidant compounds further help protect cells from oxidative stress, which can be elevated in chronic infection and inflammation.

In addition, Cistus incanus supports immune balance—helping the body mount an effective defense without triggering excessive inflammation. This balance can be critical in managing both systemic Lyme symptoms and localized heart involvement.

For people seeking a natural, research-informed botanical to complement their Lyme or Lyme carditis care plan, Linden Botanicals’ Cistus incanus extract offers a potent, sustainably sourced option.

To learn more about Cryptolepis, check out the Cistus incanus FAQ.

Persister Desister Chronic Lyme Support Kits from Linden Botanicals

For those facing the ongoing challenges of chronic or treatment-resistant Lyme disease, Linden Botanicals offers Persister Desister Chronic Lyme Support Kits—a proprietary blend of three science-supported herbal extracts: Cistus incanus (Rock Rose), Cryptolepis (Yellow Root), and Phyllanthus niruri (Chanca Piedra).

These kits are designed to address persister bacteria—the dormant forms of Borrelia burgdorferi that can evade antibiotics and contribute to persistent symptoms. Together, the three extracts work to inhibit the lifecycle of persister bacteria, re-engage the body’s natural defenses, and provide adaptogenic immune support.

In addition to their antimicrobial potential, the herbs in Persister Desister Kits help support kidney and liver health, protect against free radical damage, and promote mitochondrial function—all essential for recovery and long-term wellness. This synergistic approach offers targeted support for those seeking a comprehensive, natural strategy to complement their Lyme disease care plan.

Try Persister Desister Today

To learn more, a good place to start is with the Persister Desister FAQ and our Lyme Disease Resources.

Buy Persister Desister